A SIMIAN IMMUNODEFICIENCY VIRUS ENVELOPE V3 CYTOTOXIC T-LYMPHOCYTE EPITOPE IN RHESUS-MONKEYS AND ITS RESTRICTING MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULE MAMU-A(ASTERISK)02

被引:26
作者
WATANABE, N
MCADAM, SN
BOYSON, JE
PIEKARCZYK, MS
YASUTOMI, Y
WATKINS, DI
LETVIN, NL
机构
[1] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,BOSTON,MA 02215
[2] WISCONSIN REG PRIMATE RES CTR,MADISON,WI 53715
[3] UNIV WISCONSIN,SCH MED,DEPT PATHOL,MADISON,WI 53715
关键词
D O I
10.1128/JVI.68.10.6690-6696.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The use of the simian immunodeficiency virus (SIV) macaque model for assessing human immunodeficiency virus vaccine strategies will be facilitated by the characterization of predominant SIV cytotoxic T-lymphocyte (CTL) epitopes and their restricting major histocompatibility complex (MHC) class I molecules in macaque species. We now define a rhesus monkey SIVmac CTL epitope in the third hypervariable region of the envelope glycoprotein of the virus. This epitope, YNLTMKCR, contains the first two amino acids of a cysteine cysteine loop which is the SIVmac analog of the human immunodeficiency virus type 1 V3 loop. We also employed one-dimensional isoelectric focusing to characterize the MHC class I molecule of the rhesus monkey that binds this SIVmac envelope peptide fragment. Cloning and sequencing the cDNAenvelope peptide fragment. Cloning and sequencing the cDNA encoding this rhesus monkey MHC class I molecule demonstrates that it is a newly described HLA-A homolog, Mamu-A*02. This viral CTL epitope and its restricting MHC class I molecule will facilitate the use of the SIVmac rhesus monkey model for studies of envelope-based vaccine strategies and for exploring AIDS immunopathogenesis.
引用
收藏
页码:6690 / 6696
页数:7
相关论文
共 46 条
  • [1] CHANGMAYER C, 1990, J VIROL, V64, P4390
  • [2] CHEN ZW, 1992, J IMMUNOL, V148, P2547
  • [3] PREVENTION OF HIV-1 INFECTION IN CHIMPANZEES BY GP120 V3 DOMAIN-SPECIFIC MONOCLONAL-ANTIBODY
    EMINI, EA
    SCHLEIF, WA
    NUNBERG, JH
    CONLEY, AJ
    EDA, Y
    TOKIYOSHI, S
    PUTNEY, SD
    MATSUSHITA, S
    COBB, KE
    JETT, CM
    EICHBERG, JW
    MURTHY, KK
    [J]. NATURE, 1992, 355 (6362) : 728 - 730
  • [4] FAST P, 1993, AIDS S, pS147
  • [5] SEQUENCE OF SIMIAN IMMUNODEFICIENCY VIRUS AND ITS RELATIONSHIP TO THE HUMAN IMMUNODEFICIENCY VIRUSES
    FRANCHINI, G
    GURGO, C
    GUO, HG
    GALLO, RC
    COLLALTI, E
    FARGNOLI, KA
    HALL, LF
    WONGSTAAL, F
    REITZ, MS
    [J]. NATURE, 1987, 328 (6130) : 539 - 543
  • [6] IMMUNIZATION OF CHIMPANZEES CONFERS PROTECTION AGAINST CHALLENGE WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    GIRARD, M
    KIENY, MP
    PINTER, A
    BARRESINOUSSI, F
    NARA, P
    KOLBE, H
    KUSUMI, K
    CHAPUT, A
    REINHART, T
    MUCHMORE, E
    RONCO, J
    KACZOREK, M
    GOMARD, E
    GLUCKMAN, JC
    FULTZ, PN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) : 542 - 546
  • [7] GOODENOW M, 1989, J ACQ IMMUN DEF SYND, V2, P344
  • [8] HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 NEUTRALIZATION EPITOPE WITH CONSERVED ARCHITECTURE ELICITS EARLY TYPE-SPECIFIC ANTIBODIES IN EXPERIMENTALLY INFECTED CHIMPANZEES
    GOUDSMIT, J
    DEBOUCK, C
    MELOEN, RH
    SMIT, L
    BAKKER, M
    ASHER, DM
    WOLFF, AV
    GIBBS, CJ
    GAJDUSEK, DC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (12) : 4478 - 4482
  • [9] SPONTANEOUS SUBSTITUTIONS IN THE VICINITY OF THE V3 ANALOG AFFECT CELL TROPISM AND PATHOGENICITY OF SIMIAN IMMUNODEFICIENCY VIRUS
    HIRSCH, VM
    MARTIN, JE
    DAPOLITO, G
    ELKINS, WR
    LONDON, WT
    GOLDSTEIN, S
    JOHNSON, PR
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (04) : 2649 - 2661
  • [10] HOUGHTEN RA, 1986, BIOTECHNIQUES, V4, P522